Veterans affairs cooperative studies program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer

被引：13
|
作者：
Montgomery, Bruce [1 ]
Lavori, Philip
Garzotto, Mark
Lee, Kelvin
Brophy, Mary
Thaneemit-Chen, Surai
Kelly, William
Basler, Joseph
Ringer, Robert
Yu, Wei
Whittemore, Alice
Lin, Daniel W.
机构：
[1] Vet Affairs Puget Sound Hlth Care Syst, Div Med Oncol, Seattle, WA 98109 USA
来源：
UROLOGY | 2008年 / 72卷 / 03期
关键词：
D O I：
10.1016/j.urology.2008.02.050
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：474 / 480
页数：7
相关论文
共 50 条
  • [31] A PHASE II STUDY OF NEOADJUVANT HORMONE THERAPY AND CHEMOTHERAPY PRIOR TO PROSTATECTOMY IN HIGH-RISK PATIENTS
    Womble, Paul R.
    Van Veldhuizen, PeterJ.
    Nisbet, Alan A.
    Reed, Greg A.
    Keighley, John
    Thrasher, J. Brantley
    Holzbeierlein, Jeffrey M.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 672 - 672
  • [32] Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
    Andic, Fundagul
    Izol, Volkan
    Gokcay, Serkan
    Arslantas, Hasan Suat
    Bayazit, Yildirim
    Coskun, Hatice
    Tansug, Mustafa Zuhtu
    Sertdemir, Yasar
    BMC UROLOGY, 2019, 19 (1)
  • [33] Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
    Fundagul Andic
    Volkan Izol
    Serkan Gokcay
    Hasan Suat Arslantas
    Yildirim Bayazit
    Hatice Coskun
    Mustafa Zuhtu Tansug
    Yasar Sertdemir
    BMC Urology, 19
  • [34] Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy
    A S Kibel
    J B Nelson
    Prostate Cancer and Prostatic Diseases, 2007, 10 : 119 - 126
  • [35] Adjuvant and salvage treatment options for patients with high-risk prostate cancer treated with radical prostatectomy
    Kibel, A. S.
    Nelson, J. B.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2007, 10 (02) : 119 - 126
  • [36] Radical prostatectomy in clinically localized high-risk prostate cancer: Outcome of 231 consecutive patients
    Roder, Martin Andreas
    Berg, Kasper Drimer
    Christensen, Ib Jarle
    Gruschy, Lisa
    Brasso, Klaus
    Iversen, Peter
    SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 (01) : 19 - 25
  • [37] Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer - Comment
    Mohler, James L.
    JOURNAL OF UROLOGY, 2008, 180 (02): : 570 - 570
  • [38] Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer
    Chierigo, Francesco
    Wenzel, Mike
    Wuernschimmel, Christoph
    Flammia, Rocco Simone
    Horlemann, Benedikt
    Tian, Zhe
    Saad, Fred
    Chun, Felix K. H.
    Graefen, Markus
    Gallucci, Michele
    Shariat, Shahrokh F.
    Mantica, Guglielmo
    Borghesi, Marco
    Suardi, Nazareno
    Terrone, Carlo
    Karakiewicz, Pierre, I
    JOURNAL OF UROLOGY, 2022, 207 (02): : 376 - 383
  • [39] Re: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy before Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer
    Beuzeboc, P.
    EUROPEAN UROLOGY, 2009, 55 (04) : 992 - 992
  • [40] Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer
    Montorsi, Francesco
    Mazzone, Elio
    Gandaglia, Giorgio
    Stabile, Armando
    Salonia, Andrea
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2022, 208 (01): : 223 - 224
12345